🎉 Free to use until Sep 16, 2026 — try it out for our launch!
STOCKIQAISTOCKIQAI
עברית
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.29▲ 0.92%
TA-125₪4,069.8▲ 0.93%
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.29▲ 0.92%
TA-125₪4,069.8▲ 0.93%

ANL

Adlai Nortye Ltd. American Depositary Shares

Health Care · ·

$13.84

▲ $0.77 (+5.9%)

Market Cap

—

Day Range

$12.92 - $13.97

52-Week Range

$0.88 - $17.25

Beta

—

Next Earnings

—

ANL is a stock from the Healthcare sector — Pharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.

🏢 Similar Stocks in the Same Sector

AAPG

Ascentage Pharma Group International - American Depository

AARD

Aardvark Therapeutics, Inc.

ABCL

AbCellera Biologics Inc. - Common

+792.9% (1Y)

Some data (financial/growth/valuation) is currently unavailable — the daily API quota was likely exhausted. The score is computed from 3 of 7 available categories. Try again later for the full analysis.
Investor Score
65/ 100B-
🟡 Moderate

This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer

📈73BTechnical
💰—Fundamental
🚀—Growth
💎—Valuation
📰56CNews
🏦—Quality
⚠️42DRisk

Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%

🔍 Cross-Check

Overall Score

🟡 Mixed

Technical Trend

🟢 Bullish

Insiders

🔴 Bearish

✅ Why is the score relatively high?

  • 🟢 Price is above the 50-day average
  • 🟢 Price is above the 200-day average
  • 🟢 MACD histogram is positive — rising momentum
  • 🟢 RSI 64.1 — healthy positive momentum
  • 🟢 Price is above the SAR point — uptrend

⚠️ What's concerning?

  • 🔴 ATR: 8.5% of price
  • 🔴 -7.7% over the last 3 months relative to the index
  • 🔴 %K 96.4 — overbought
  • 🔴 Volume is falling despite the price advance — possible weakening

🚦 Quality & Risk Checks

🔴 Daily volatility (ATR)

📰 News Trend

Based on real financial news (Finnhub)
🟡 Mixed

Everyone's writing about Adlai Nortye Ltd. American Depositary Shares. News trend score: 56. Reason: 3 of the last 9 articles are positive, versus 2 negative.

🔴 Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia — GlobeNewswire🔴 Adlai Nortye Submits Clinical Trial Notification To Australia's TGA And Receives Approval From HREC To Commence Phase I Clinical Trial Evaluating AN4035 For Treatment Of CEACAM5-Enriched RAS-Addicted Solid Tumors — Benzinga🟡 Adlai Nortye: AN9025 Still Needs Human Validation — SeekingAlpha

News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer

📈 Technical Analysis

Based on the last 251 trading days, calculated from real price data. Click an indicator for details and a chart.

🟢 Most indicators support an uptrend (8 bullish · 3 bearish · 1 neutral)

Conclusions

  • 🟢Price vs. SMA 50 — Price is above the 50-day average
  • 🟢Price vs. SMA 200 — Price is above the 200-day average
  • 🟢MACD — MACD histogram is positive — rising momentum
  • 🟢RSI — RSI 64.1 — healthy positive momentum
  • 🔴Stochastic — %K 96.4 — overbought
  • 🟡ADX (trend strength) — ADX 9.2 — weak trend/choppy
  • 🔴Volume trend — Volume is falling despite the price advance — possible weakening
  • 🔴Relative strength vs. S&P 500 — -7.7% over the last 3 months relative to the index
  • 🟢Bollinger Bands — Price is in the upper third of the Bollinger Bands (83%B) — strong momentum (risk of a pullback)
  • 🟢ROC (rate of change) — ROC 12 days: 6.5%
  • 🟢Parabolic SAR — Price is above the SAR point — uptrend
  • 🟢CMF (money flow) — CMF 20 days: 0.32

Wyckoff Method Analysis

A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.

Markup

The stock is in a clear uptrend with no defined trading range in the period examined.

High confidence

Evidence Behind This Read

  • 🟢Rising price trend — A 25.8% change over the last 50 days, with no defined trading range.

The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.

🎯 Trade Planning (M.A.E.E Framework)

Based on a mechanical trading method: market structure → value zone → ATR-based exit point. Not investment advice — a calculation tool only.

1️⃣ Market Structure

🟢 Uptrend

The price is above the 200-day average — per the market-structure method, this environment mainly favors looking for buying (Long) opportunities.

2️⃣ Value Zone

🟡 Price far from value zone

The price is currently far from the 50-day average — the method recommends waiting for a "pullback" before entering, rather than chasing prices.

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = support minusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Entry

$13.84

Stop-Loss

$7.37

Risk per Share

$6.47

Direction

Long

Profit Targets by Risk/Reward Ratio (R)

1:2 R

$26.78

1:3 R

$33.26

1:5 R

$46.20

💰 Position Size Calculator

A core principle of the method: never risk a fixed dollar amount — risk a fixed percentage of equity, and let the position size vary according to the risk per share.

Suggested Position Size

15 sh.

🕴️ Insider Trading

Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 1 sales out of the last 2 filings.

NameTransaction TypeDateSharesChangePrice
Ji PingOther Transaction10.6.2026136,667+136,667—
LU YANGOpen Market Sale13.5.202699,990-10$13.18

📉 Short Interest

Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.

Monthly Trend — Open Short Interest

↑+5.5%

3,518,214 shares short as of 2026-07-15 · vs. 3,335,395 on 2026-06-30

Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.

Weekly Trend — Daily Short-Sale Activity

↓-23.4%

54.3% of trading volume this week was short selling, vs. 70.8% the prior week

Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.

📰 News & Sentiment

Sentiment based on basic keywords (not AI) — 3 positive, 4 neutral, 2 negative out of the last 9 articles.